DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 12 · Volume 70 · 1993 DOI: 10.1055/s-008-40610

Review Article

  • 0884
    Fox, Joan E B:

    The Platelet Cytoskeleton

    • Original Article

    Clinical Studies

  • 0894
    Hoffmann, J J M L; Hennis, B C; Kluft, C; Vijgen, M:

    Hereditary Increase of Plasma Histidine-Rich Glycoprotein Associated with Abnormal Heparin Binding (HRG Eindhoven)

  • 0900
    Nilsen, D W T; Almdahl, S M; Svensson, B; Vaage, J; Rasmussen, K; Østerud, B:

    Lipopolysaccharide Induced Monocyte Thromboplastin Synthesis and Coagulation Responses in Patients Undergoing Coronary Bypass Surgery after Preoperative Supplementation with n-3 Fatty Acids

  • 0903
    Pieters, H; Roodt, J P; Badenhorst, P N; van Wyk, V; Schall, R; Lötter, M G; Hundt, H K L; Nel, C J C:

    Antithrombotic Activity of Bay u3405, a Thromboxane A2-Antagonist, in Patients with Dacron Aortic Grafts: a Random Controlled Clinical Trial

  • 0909
    The DVTENOX Study Group:

    Markers of Hemostatic System Activation in Acute Deep Venous Thrombosis-Evolution during the First Days of Heparin Treatment

  • 0915
    Green, Fiona; Hamsten, Anders; Blombäck, Margareta; Humphries, Steve:

    The Role of β-Fibrinogen Genotype in Determining Plasma Fibrinogen Levels in Young Survivors of Myocardial Infarction and Healthy Controls from Sweden

  • 0921
    Tripodi, Armando; Arbini, Arnaldo A; Chantarangkul, Veena; Bettega, Donato; Mannucci, Pier Mannuccio:

    Are Capillary Whole Blood Coagulation Monitors Suitable for the Control of Oral Anticoagulant Treatment by the International Normalized Ratio?

  • 0925
    Triplett, Douglas A; Stocker, Kurt F; Unger, Gail A; Barna, Linda K:

    The Textarin/Ecarin Ratio: A Confirmatory Test for Lupus Anticoagulants

  • 0932
    Gray, Rosaire P; Hendra, Timothy J; Patterson, David L H; Yudkin, John S:

    “Spontaneous” Platelet Aggregation in Whole Blood in Diabetic and Non Diabetic Survivors of Acute Myocardial Infarction

  • 0937
    Andrew, Maureen; MacIntyre, Brian; MacMillan, James; Williams, William G; Gruenwald, Colleen; Johnston, Marilyn; Burrows, Fred; Wang, Elaine; Adams, Margaret:

    Heparin Therapy during Cardiopulmonary Bypass in Children Requires Ongoing Quality Control

    • Coagulation

  • 0942
    Harenberg, Job; Siegele, Marietta; Dempfle, Carl-Erik; Stehle, Gerd; Heene, Dieter L:

    Protamine Neutralization of the Release of Tissue Factor Pathway Inhibitor Activity by Heparins

  • 0946
    Boyer-Neumann, C; Bertina, R M; Tripodi, A; D'Angelo, A; Wolf, M; D'Angelo, S Vigano; Mannucci, P M; Meyer, D; Larrieu, M J:

    Comparison of Functional Assays for Protein S: European Collaborative Study of Patients with Congenital and Acquired Deficiency

  • 0951
    Zammit, Adrian; Pepper, Duncan S; Dawes, Joan:

    Interaction of Immobilised Unfractionated and LMW Heparins with Proteins in Whole Human Plasma

  • 0959
    Rotteveel, R C; Roozendaal, K J; Eijsman, L; Hemker, H C:

    The Influence of Oral Contraceptives on the Time-Integral of Thrombin Generation (Thrombin Potential)

  • 0963
    Gupta, Madhu; Doellgas, George J; Cheng, Therese; Lewis, Jon C:

    Expression and Localization of Tissue Factor-Based Procoagulant Activity (PCA) in Pigeon Monocyte-Derived Macrophages

  • 0970
    Neuenschwander, Pierre F; Branam, Dannielle E; Morrissey, James H:

    Importance of Substrate Composition, pH and Other Variables on Tissue Factor Enhancement of Factor Vlla Activity

    • Fibrinolysis

  • 0978
    Regano, Edelmiro; Vila, Virtudes; Aznar, Justo; Lacueva, Victoria; Martinez, Vicenta; Ruano, Miguel:

    Studies on the Functionality of Newly Synthesized Fibrinogen after Treatment of Acute Myocardial Infarction with Streptokinase, Increase in the Rate of Fibrinopeptide Release

  • 0984
    Wilson, S; Cronk, D W; Dodd, I; Esmail, A F; Kalindjian, S B; McMurdo, L; Browne, M J; Smith, R A G; Robinson, J H:

    The Use of Active Centre Acylation to Control the Pharmacokinetic Profile of a Recombinant Chimaeric Plasminogen Activator

  • 0989
    España, Francisco; Estellés, Amparo; Fernández, Pedro J; Gilabert, Juan; Sánchez-Cuenca, Jaime; Griffin, John H:

    Evidence for the Regulation of Urokinase and Tissue Type Plasminogen Activators by the Serpin, Protein C Inhibitor, in Semen and Blood Plasma

  • 0995
    Brommer, E J P; Meijer, P:

    Thrombin Generation Induced by the Intrinsic or Extrinsic Coagulation Pathway is Accelerated by Streptokinase, Independently of Plasminogen

  • 0998
    Önundarson, Páll T; Haraldsson, H Magnús; Bergmann, Lena; Francis, Charles W; Marder, Victor J:

    Plasminogen Depletion during Streptokinase Treatment or Two-Chain Urokinase Incubation Correlates with Decreased Clot Lysability Ex Vivo and In Vitro

  • 1005
    Wallnöfer, A E; van Griensven, J M T; Schoemaker, H C; Cohen, A F; Lambert, W; Kluft, C; Meijer, P; Kooistra, T:

    Effect of Isotretinoin on Endogenous Tissue-Type Plasminogen Activator (t-PA) and Plasminogen Activator Inhibitor 1 (PAI-1) in Humans

  • 1009
    Padayatty, S J; Orme, S; Zenobi, P D; Stickland, M H; Belchetz, P E; Grant, P J:

    The Effects of Insulin-Like Growth Factor-1 on Plasminogen Activator Inhibitor-1 Synthesis and Secretion: Results from In Vitro and In Vivo Studies

  • 1014
    Teng, Che-Ming; Lin, Chien-Huang; Lin, Chun-Nan; Chung, Mei-lng; Huang, Tur-Fu:

    Frangulin B, an Antagonist of Collagen-Induced Platelet Aggregation and Adhesion, Isolated from Rhamnus formosana

  • 1019
    Kinlough-Rathbone, R L; Perry, D W; Guccione, M A; Rand, M L; Packham, M A:

    Degranulation of Human Platelets by the Thrombin Receptor Peptide SFLLRN: Comparison with Degranulation by Thrombin

  • 1024
    Smeets, E F; Heemskerk, J W M; Comfurius, P; Bevers, E M; Zwaal, R F A:

    Thapsigargin Amplifies the Platelet Procoagulant Response Caused by Thrombin

  • 1030
    Varon, David; Lider, Ofer; Dardik, Rima; Shenkman, Boris; Alon, Ronen; Hershkoviz, Rami; Kapustina, Galina; Savion, Naftali; Martinowitz, Uri; Greenspoon, Noam:

    Inhibition of Integrin-Mediated Platelet Aggregation, Fibrinogen-Binding, and Interactions with Extracellular Matrix by Nonpeptidic Mimetics of Arg-Gly-Asp

    • Von Willebrand Factor and Endothelial Cells

  • 1037
    Martin, N B; Jamieson, A; Tuffin, D P:

    The Effect of Interleukin-4 on Tumour Necrosis Factor-Alpha Induced Expression of Tissue Factor and Plasminogen Activator Inhibitor-1 in Human Umbilical Vein Endothelial Cells

  • 1043
    Smalley, David M; Fitzgerald, John E; O'Rourke, James:

    Adenosine Diphosphate Stimulates the Endothelial Release of Tissue-Type Plasminogen Activator but not von Willebrand Factor from Isolated-Perfused Rat Hind Limbs

  • 1047
    Wang, Jian; Dudman, Nicholas P B; Wilcken, David E L:

    Effects of Homocysteine and Related Compounds on Prostacyclin Production by Cultured Human Vascular Endothelial Cells

  • 1053
    Journet, Agnès M; Saffaripour, Simin; Wagner, Denisa D:

    Requirement for Both D Domains of the Propolypeptide in von Willebrand Factor Muitimerization and Storage

  • 1058
    Inbal, Aida; Kornbrot, Nurit; Harrison, Paul; Randi, Anna M; Sadler, J Evan:

    Effect of Type IIB von Willebrand Disease Mutation Arg(545)Cys on Platelet Glycoprotein Ib Binding – Studies with Recombinant von Willebrand Factor

    • Letter to the Editor

  • 1063
    Ajzenberg, N; Cherin, P; Diallo, D; Bridey, F; Brivet, F; Dreyfus, M:

    In Vivo Effect of Echis carinatus Venom Observed in a Woman in Mali

  • 1064
    Mertes, Günter; Ludwig, Michael; Schwaab, Rainer; Brackmann, Hans-Her-mann; Olek, Klaus:

    ΔC in Exon 18 of the von Willebrand Gene Is Uncommon in German vWD Type III Patients

  • 1065
    Barrowcliffe, Trevor W; Kemball-Cook, Geoffrey; Tubbs, Jill E:

    Inhibitor Development and Activated Factor VIII in Concentrates

    • Rapid Communication

  • 1067
    Faioni, E M; Franchi, F; Asti, D; Sacchi, E; Bernardi, F; Mannucci, P M:

    Resistance to Activated Protein C in Nine Thrombophilic Families: Interference in a Protein S Functional Assay